Dr. Reddy's Laboratories
231 hedge funds and large institutions have $1.73B invested in Dr. Reddy's Laboratories in 2024 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 93 increasing their positions, 73 reducing their positions, and 20 closing their positions.
161% more call options, than puts
Call options by funds: $1.91M | Put options by funds: $733K
45% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 20
27% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 73
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
5% more capital invested
Capital invested by funds: $1.64B → $1.73B (+$87.7M)
3% more funds holding
Funds holding: 224 → 231 (+7)
0.07% less ownership
Funds ownership: 70.88% → 70.81% (-0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$24M |
| 2 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$18.2M |
| 3 |
JP Morgan Chase
New York
|
+$16.3M |
| 4 |
Millennium Management
New York
|
+$13.6M |
| 5 |
AIM
Aikya Investment Management
London,
United Kingdom
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$60.1M |
| 2 |
Goldman Sachs
New York
|
-$20.3M |
| 3 |
Lazard Asset Management
New York
|
-$13.1M |
| 4 |
Neuberger Berman Group
New York
|
-$8.98M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$7.55M |
RDY Hedge Fund Activity: Q1 2024 in Review
231 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2024, worth a combined $1.73B — up 5.3% from $1.64B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new RDY positions and 20 closed out — a net gain of 9 holders — while 93 added to existing stakes and 73 trimmed.
The largest buyer was Bank of America, adding an estimated $24M. The largest seller was BlackRock, cutting an estimated $60.1M.
- 231 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2024, up from 224 in Q4 2023.
- Funds reported $1.73B of Dr. Reddy's Laboratories stock for Q1 2024, up 5.3% quarter-over-quarter.
- 29 funds opened new Dr. Reddy's Laboratories positions in Q1 2024 and 20 closed out, a net change of +9 holders.
- The largest Dr. Reddy's Laboratories buyer in Q1 2024 was Bank of America, an estimated $24M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2024 was BlackRock, an estimated $60.1M sold.
Based on aggregated 13F filings for Q1 2024.